AI Article Synopsis

  • Megakaryocyte (MK) development in bone marrow involves a process where MK progenitors initially proliferate in the endosteal niche and then mature in the sinusoidal vascular niche, crucial for platelet production.
  • The chemokine SDF-1, through its receptor CXCR4, guides the movement of MKs toward blood vessels, enhancing their association with the vasculature and stimulating thrombopoiesis without increasing the overall number of MKs.
  • Alterations in SDF-1 distribution, especially after radiation injury, impact MK localization and, consequently, platelet production, suggesting that manipulating SDF-1 can help treat conditions like radiation-induced thrombocytopenia.

Article Abstract

Megakaryocyte (MK) development in the bone marrow progresses spatially from the endosteal niche, which promotes MK progenitor proliferation, to the sinusoidal vascular niche, the site of terminal maturation and thrombopoiesis. The chemokine stromal cell-derived factor-1 (SDF-1), signaling through CXCR4, is implicated in the maturational chemotaxis of MKs toward sinusoidal vessels. Here, we demonstrate that both IV administration of SDF-1 and stabilization of endogenous SDF-1 acutely increase MK-vasculature association and thrombopoiesis with no change in MK number. In the setting of radiation injury, we find dynamic fluctuations in marrow SDF-1 distribution that spatially and temporally correlate with variations in MK niche occupancy. Stabilization of altered SDF-1 gradients directly affects MK location. Importantly, these SDF-1-mediated changes have functional consequences for platelet production, as the movement of MKs away from the vasculature decreases circulating platelets, while MK association with the vasculature increases circulating platelets. Finally, we demonstrate that manipulation of SDF-1 gradients can improve radiation-induced thrombocytopenia in a manner additive with earlier TPO treatment. Taken together, our data support the concept that SDF-1 regulates the spatial distribution of MKs in the marrow and consequently circulating platelet numbers. This knowledge of the microenvironmental regulation of the MK lineage could lead to improved therapeutic strategies for thrombocytopenia.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093683PMC
http://dx.doi.org/10.1182/blood-2014-01-547638DOI Listing

Publication Analysis

Top Keywords

sdf-1
8
niche occupancy
8
radiation injury
8
sdf-1 gradients
8
circulating platelets
8
sdf-1 dynamically
4
dynamically mediates
4
mediates megakaryocyte
4
niche
4
megakaryocyte niche
4

Similar Publications

Notably, the C-X-C Motif Chemokine Ligand 12/C-X-C Chemokine Receptor Type 4 (CXCL12/CXCR4) signalling pathway's activation is markedly increased in a mouse model of abdominal aortic aneurysms (AAA). Nonetheless, the precise contribution of this pathway to AAA development remains to be elucidated. The AAA mouse model was induced by local incubation with elastase and oral administration of β-aminopropionitrile.

View Article and Find Full Text PDF

CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection.

J Clin Invest

January 2025

Department of Microbiology and Immunology, University of Iowa, Iowa City, United States of America.

Neutrophils, particularly low-density neutrophils (LDNs), are believed to contribute to acute COVID-19 severity. Here, we showed that neutrophilia can be detected acutely and even months after SARS-CoV-2 infection in patients and mice, while neutrophil depletion reduced disease severity in mice. A key factor in neutrophilia and severe disease in infected mice was traced to the chemokine CXCL12 secreted by bone marrow cells and unexpectedly, endothelial cells.

View Article and Find Full Text PDF

Background: The metastasis-promoting G-protein-coupled receptor CXC Receptor 4 (CXCR4) is activated by the chemokine CXCL12, also known as stromal cell-derived factor 1 (SDF-1). The CXCL12/CXCR4 pathway in cancer promotes metastasis but the molecular details of how this pathway cross-talks with oncogenes are understudied. An oncogene pathway known to promote breast cancer metastasis in MDA-MB-231 xenografts is that of Mouse Double Minute 2 and 4 (MDM2 and MDM4, also known as MDMX).

View Article and Find Full Text PDF

Background: Meniscal injuries that fail to heal instigate catabolic changes in the knee's microenvironment, posing a high risk for developing posttraumatic osteoarthritis (PTOA). Previous research has suggested that human cartilage-derived progenitor cells (hCPCs) can stimulate meniscal repair in a manner that depends on stromal cell-derived factor 1 (SDF-1) pathway activity.

Hypothesis: Overexpressing the SDF-1 receptor CXCR4 in hCPCs will increase cell trafficking and further improve the repair efficacy of meniscal injuries.

View Article and Find Full Text PDF
Article Synopsis
  • Retinal pathological angiogenesis (PA) is linked to diseases like age-related macular degeneration and diabetic retinopathy, and this study explores the role of the protein biglycan (BGN) in this process using a mouse model.
  • The researchers found that BGN levels increased in the retinas of mice with oxygen-induced retinopathy and that inhibiting BGN led to reduced PA, suggesting BGN plays a crucial role in promoting this condition.
  • Further analysis indicated that BGN's effect on PA may involve the upregulation of another protein, CXCL12, and blocking the interaction between CXCL12 and its receptor significantly decreased PA in mice, highlighting the importance of pericytes in
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!